EBP Compendium: Summary of Systematic Review
The Cochrane Collaboration
Hyperbaric Oxygen for Idiopathic Sudden Sensorineural Hearing Loss and Tinnitus
Bennett, M., Kertesz, T., et al.
Cochrane Database of Systematic Reviews(1).
Indicators of Review Quality:
The review addresses a clearly focused question
Criteria for inclusion of studies are provided
Search strategy is described in sufficient detail for replication
Included studies are assessed for study quality
Quality assessments are reproducible
Description: This is a review of randomized studies comparing the effects of hyperbaric oxygen therapy (HBOT) and treatment without HBOT on idiopathic sudden sensorineural hearing loss (ISSHL) and/or tinnitus.
- Does the administration of hyperbaric oxygen to people with idiopathic sensorineural hearing loss (whether early or late presentation) result in an increase in the proportion attaining a useful improvement in hearing?
- Does the administration of hyperbaric oxygen to people with tinnitus (whether early or late presentation) result in an increase in the proportion experiencing a useful reduction in tinnitus?
Population: Adults with acute onset of sensorineural hearing loss and/or tinnitus
Intervention/Assessment: Hyperbaric oxygen therapy (HBOT)
Number of Studies Included: 6
Years Included: 1966 - 2006
This review supports the use of HBOT as an effective treatment for improving hearing loss in the early presentation of ISSHL. Effects of HBOT for the treatment of tinnitus cannot be determined from this review. Results of this review should be considered with caution secondary reduced methodological quality of included studies (Abstract p. 2).
Keywords: Hearing Loss, Tinnitus
Access the Review
Added to Compendium: January 2012